Tumor Habitat Analysis Using Longitudinal Physiological MRI to Predict Tumor Recurrence After Stereotactic Radiosurgery for Brain Metastasis

Objective It is difficult to predict the treatment response of tissue after stereotactic radiosurgery (SRS) because radiation necrosis (RN) and tumor recurrence can coexist. Our study aimed to predict tumor recurrence, including the recurrence site, after SRS of brain metastasis by performing a longitudinal tumor habitat analysis. Materials and Methods Two consecutive multiparametric MRI examinations were performed for 83 adults (mean age, 59.0 years; range, 27–82 years; 44 male and 39 female) with 103 SRS-treated brain metastases. Tumor habitats based on contrast-enhanced T1- and T2-weighted images (structural habitats) and those based on the apparent diffusion coefficient (ADC) and cerebral blood volume (CBV) images (physiological habitats) were defined using k-means voxel-wise clustering. The reference standard was based on the pathology or Response Assessment in Neuro-Oncologycriteria for brain metastases (RANO-BM). The association between parameters of single-time or longitudinal tumor habitat and the time to recurrence and the site of recurrence were evaluated using the Cox proportional hazards regression analysis and Dice similarity coefficient, respectively. Results The mean interval between the two MRI examinations was 99 days. The longitudinal analysis showed that an increase in the hypovascular cellular habitat (low ADC and low CBV) was associated with the risk of recurrence (hazard ratio [HR], 2.68; 95% confidence interval [CI], 1.46–4.91; P = 0.001). During the single-time analysis, a solid low-enhancing habitat (low T2 and low contrast-enhanced T1 signal) was associated with the risk of recurrence (HR, 1.54; 95% CI, 1.01–2.35; P = 0.045). A hypovascular cellular habitat was indicative of the future recurrence site (Dice similarity coefficient = 0.423). Conclusion After SRS of brain metastases, an increased hypovascular cellular habitat observed using a longitudinal MRI analysis was associated with the risk of recurrence (i.e., treatment resistance) and was indicative of recurrence site. A tumor habitat analysis may help guide future treatments for patients with brain metastases.

[1]  Anum S. Kazerouni,et al.  Quantifying Tumor Heterogeneity via MRI Habitats to Characterize Microenvironmental Alterations in HER2+ Breast Cancer , 2022, Cancers.

[2]  T. Krings,et al.  The centrally restricted diffusion sign on MRI for assessment of radiation necrosis in metastases treated with stereotactic radiosurgery , 2021, Journal of Neuro-Oncology.

[3]  Da Hyun Lee,et al.  Tumor habitat analysis by magnetic resonance imaging distinguishes tumor progression from radiation necrosis in brain metastases after stereotactic radiosurgery , 2021, European Radiology.

[4]  D. Schadendorf,et al.  EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours. , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  R. Gillies,et al.  The Biological Meaning of Radiomic Features. , 2021, Radiology.

[6]  P. Wen,et al.  Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. , 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

[7]  E. Moros,et al.  Integrating Mathematical Modeling into the Roadmap for Personalized Adaptive Radiation Therapy. , 2019, Trends in cancer.

[8]  J. Olson,et al.  Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Use of Stereotactic Radiosurgery in the Treatment of Adults With Metastatic Brain Tumors , 2019, Neurosurgery.

[9]  David Bonekamp,et al.  Automated brain extraction of multisequence MRI using artificial neural networks , 2019, Human brain mapping.

[10]  V. Sawlani,et al.  Evaluation of Response to Stereotactic Radiosurgery in Brain Metastases Using Multiparametric Magnetic Resonance Imaging and a Review of the Literature. , 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

[11]  Robert J. Gillies,et al.  Quantitative imaging of cancer in the postgenomic era: Radio(geno)mics, deep learning, and habitats , 2018, Cancer.

[12]  C. Fuller,et al.  Spatial habitats from multiparametric MR imaging are associated with signaling pathway activities and survival in glioblastoma , 2017, Oncotarget.

[13]  Daya Luo,et al.  Factors involved in cancer metastasis: a better understanding to “seed and soil” hypothesis , 2017, Molecular Cancer.

[14]  M. Fukayama,et al.  Detection of residual metastatic tumor in the brain following Gamma Knife radiosurgery using a single or a series of magnetic resonance imaging scans: An autopsy study , 2017, Oncology letters.

[15]  J. Brenton,et al.  Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging. , 2017, Clinical radiology.

[16]  Jennifer S. Yu,et al.  Review of cranial radiotherapy-induced vasculopathy , 2015, Journal of Neuro-Oncology.

[17]  Samuel T Chao,et al.  Challenges with the diagnosis and treatment of cerebral radiation necrosis. , 2013, International journal of radiation oncology, biology, physics.

[18]  Nicholas F. Marko,et al.  Cerebral radiation necrosis: A review of the pathobiology, diagnosis and management considerations , 2013, Journal of Clinical Neuroscience.

[19]  Surjith Vattoth,et al.  Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence. , 2012, Radiographics : a review publication of the Radiological Society of North America, Inc.

[20]  G. Barnett,et al.  Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery , 2012, Journal of Neuro-Oncology.

[21]  S. Kim,et al.  Analysis of the layering pattern of the apparent diffusion coefficient (ADC) for differentiation of radiation necrosis from tumour progression , 2012, European Radiology.

[22]  R. Jain,et al.  The biology of brain metastases—translation to new therapies , 2011, Nature Reviews Clinical Oncology.

[23]  M. Endo,et al.  Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery , 2010, Journal of Neuro-Oncology.

[24]  D. Knol,et al.  Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence , 2009, Journal of Neurology.

[25]  J. Posner,et al.  Brain metastases: epidemiology and pathophysiology , 2005, Journal of Neuro-Oncology.

[26]  L. R. Dice.  Measures of the Amount of Ecologic Association Between Species , 1945 .